User:Ryan Sanni

Ryan R. Sanni (born August 3, 1993) is an American born Eagle Scout and Fourth year medical student known for his work in publishing medical research.[1]

Ryan R. Sanni (born August 3, 1993) is an American born Eagle Scout and Fourth year medical student known for his work in publishing medical research.[1]


Early years:

Sanni was born in South Bend, Indiana. He was raised in Columbus, Georgia, and has one brother


Career:

Ryan Sanni specializes in networking, drafting, submitting, and publishing research with an emphasis in extreme levels of calcium and sarcoidosis. Sanni also does speaking engagements nationally relating to his research in sarcoidosis. Sanni also is an aspiring physician and attends Windsor University School of Medicine.


Writing:

Sanni is the first author of three medical research publications.

His first, written as a third year medical student, is titled Extreme Hypercalcemia of Malignancy.[2]

His second, written as a third year medical student, is titled Cardiac Sarcoidosis.[3]

His latest publication is titled Pseudobulbar Affect.[4]

Sanni has also published presentations on the Role of Adjuvants and Pediatric Respiratory Disease



Personal Life:

Sanni lives in Chicago, Illinois. He is an avid outdoor enthusiast who enjoys camping, backpacking, and canoeing


Publications

Sanni, R.R., & Tiesenga, F.M., & Schubert, C.B., & Jorge, J.M., & Mellacheruvu S.. Cardiac Sarcoidosis. Cardiac Sarcoidosis. 2019, Jun; 59(6): 189-192. Cited in PubMed; PMID: Consultant. Pub Status: Published.

Sanni, R.R, & Tiesenga F.M, & Mellacheruvu, S.. (2019, August 29). Pseudobulbar Affect. https://www.consultant360.com/article/consultant360/pseudobulbar-affect, Pub Status: Published.

Sanni, R.R., & Khosla, K., & Bheemanathini, V., & Dupaya, D.C.. (2019, February 15). Extreme Hypercalcemia of Malignancy. https://www.consultant360.com/article/consultant360/extreme-hypercalcemia-malignancy, Pub Status: Published.

Sanni, R.R.. (2019, March 12). Adjuvants. https://www.slideshare.net/RyanSanni1/adjuvants-135768509, Pub Status: Published.[5]

Sanni, R.R.. (2019, May 07). Respiratory Disease - Pediatrics. https://www.slideshare.net/RyanSanni1/respiratory-disease-pediatrics, Pub Status: Published.[6]


References

1) https://www.consultant360.com/article/consultant360/extreme-hypercalcemia-malignancy

2) https://www.consultant360.com/article/cardiology/cardiac-sarcoidosis

3) https://www.consultant360.com/article/consultant360/pseudobulbar-affect

4) https://www.slideshare.net/RyanSanni1/adjuvants-135768509. Published March 12, 2019. DOI: 10.6084/m9.figshare.7828796

5) https://www.slideshare.net/RyanSanni1/respiratory-disease-pediatrics. Published May 7, 2019. DOI:10.6084/m9.figshare.8091209

6) https://www.researchgate.net/profile/Ryan_Sanni

7) https://resident360.nejm.org/profiles/ryanrsanni

8) https://www.linkedin.com/in/ryanrsanni2020/

  1. ^ www.consultant360.com https://www.consultant360.com/article/cardiology/cardiac-sarcoidosis. Retrieved 2020-01-11. {{cite web}}: Missing or empty |title= (help)
  2. ^ www.consultant360.com https://www.consultant360.com/article/consultant360/extreme-hypercalcemia-malignancy. Retrieved 2020-01-11. {{cite web}}: Missing or empty |title= (help)
  3. ^ www.consultant360.com https://www.consultant360.com/article/cardiology/cardiac-sarcoidosis. Retrieved 2020-01-11. {{cite web}}: Missing or empty |title= (help)
  4. ^ www.consultant360.com https://www.consultant360.com/article/consultant360/pseudobulbar-affect. Retrieved 2020-01-11. {{cite web}}: Missing or empty |title= (help)
  5. ^ RyanSanni1 (2019-03-12). "Adjuvants". {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: numeric names: authors list (link)
  6. ^ RyanSanni1 (2019-05-07). "Respiratory Disease - Pediatrics". {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: numeric names: authors list (link)

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.